A5070557002- Tuberculosis Research and Epidemiology
- Antibiotic Use and Resistance
- Pneumocystis jirovecii pneumonia detection and treatment
- Infectious Diseases and Tuberculosis
- Diagnosis and treatment of tuberculosis
- Pneumonia and Respiratory Infections
- Mycobacterium research and diagnosis
- COVID-19 epidemiological studies
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- Vaccine Coverage and Hesitancy
- COVID-19 Clinical Research Studies
- COVID-19 diagnosis using AI
- Pharmaceutical Practices and Patient Outcomes
- Global Maternal and Child Health
- Reproductive tract infections research
- HIV/AIDS drug development and treatment
- Influenza Virus Research Studies
- Respiratory viral infections research
- Viral Infections and Outbreaks Research
- HIV/AIDS Research and Interventions
- Patient Satisfaction in Healthcare
- Urinary Tract Infections Management
- Adolescent Sexual and Reproductive Health
- Pharmaceutical Economics and Policy
University of Ottawa
2023-2024
Ottawa Hospital Research Institute
2023-2024
Ottawa Hospital
2023-2024
McGill University Health Centre
2020-2023
Başkent University Hospital
2023
Universitat de Barcelona
2023
Barcelona Institute for Global Health
2023
European Respiratory Society
2023
McGill University
2017-2022
McMaster University
2022
Rising rates of antimicrobial resistance (AMR) globally continue to pose agrave threat human health. Low- and middle-income countries (LMICs) are disproportionately affected, partly due the high burden communicable diseases.We reviewed current trends in AMR LMICs examined forces driving those regions. The state interventions being undertaken curb across developing world discussed, impact COVID-19 pandemic on efforts is explored.The dynamics that drive inseparable from political, economic,...
Background We assessed the impact of coronavirus disease 2019 (COVID-19) epidemic in India on consumption antibiotics and hydroxychloroquine (HCQ) private sector 2020 compared to expected level use had not occurred. Methods findings performed interrupted time series (ITS) analyses sales volumes reported standard units (i.e., doses), collected at regular monthly intervals from January 2018 December obtained IQVIA, India. As children are less prone develop symptomatic severe acute respiratory...
No large study has ever evaluated the efficacy, safety and tolerability of meropenem/clavulanate to treat multidrug- extensively drug-resistant tuberculosis (MDR- XDR-TB). The aim this observational was evaluate therapeutic contribution, effectiveness, profile added a background regimen when treating MDR- XDR-TB cases. Patients treated with meropenem/clavulanate-containing (n=96) showed greater drug resistance than those exposed meropenem/clavulanate-sparing (n=168): in former group more...
Determining whether antibiotic prescriptions are inappropriate requires knowledge of patients' underlying conditions. In low-income and middle-income countries (LMICs), where misdiagnoses frequent, this is challenging. Additionally, such details often unavailable for prescription audits. Recent studies using standardised patients (SPs) offer a unique opportunity to generate unbiased prevalence estimates overuse, as the research design involves with predefined conditions.Secondary analyses...
No large study to date has ever evaluated the effectiveness, safety and tolerability of imipenem/clavulanate versus meropenem/clavulanate treat multidrug- extensively drug-resistant tuberculosis (MDR- XDR-TB). The aim this observational was compare therapeutic contribution added background regimens MDR- XDR-TB cases. 84 patients treated with imipenem/clavulanate-containing showed a similar median number antibiotic resistances (8 8) but more fluoroquinolone resistance (79.0% 48.9%,...
<h3>BACKGROUND:</h3> Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely passive, which impedes epidemic control. We defined active testing strategies SARS-CoV-2 using reverse transcription polymerase chain reaction (RT-PCR) groups at increased risk of acquiring in all Canadian provinces. <h3>METHODS:</h3> identified 5 who should be prioritized RT-PCR testing: contacts people are positive SARS-CoV-2, and 4 at-risk populations — hospital employees, community...
Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 December 29, 2020, assess factors associated with COVID-19 vaccination willingness and reasons or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very somewhat vaccine; 15.9% CI: 15.4, 16.3)...
Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities people affected by TB are experts in their care pathways, but field continues to fall short meaningfully engaging communities research. This a missed opportunity improve quality, relevance, person-centeredness, positive impact, sustainability research outputs. We acknowledge important progress that has been made date regarding community engagement TB,...
As tuberculosis (TB) spreads beyond borders with people movements, several interventions ensuring the continuity of care are essential, although difficult to put in place absence well-defined agreements allowing data sharing and easy referral patients appropriate health facilities. This article first sets out general principles for cross-border collaboration care. It then presents a series case studies. Policies practices on selected low-incidence countries (Australia, Italy, Norway, The...